Stockwatch

If you had invested ₹10,000 in Mankind Pharma in 2023

Worth at the close on 11 Sep 2026
₹15,944
+59.4% Gain of ₹5,944 over 3.3 years.
Invested
₹10,000
On
09 May 2023
Price then
₹1,430
Price now
₹2,280
Annualised
+15.0%
Multiple
1.59×
₹7,500₹10,000₹12,500₹15,000₹17,500₹20,0002023202420252026
Mankind Pharma NIFTY 50, same money same dates What you put in

Value of ₹10,000 invested on 09 May 2023, month by month.

Was that any good?

The same money, somewhere else

WhereWorth nowChange Against MANKIND
Mankind Pharma ₹15,944 +59.4%
NIFTY 50 ₹12,810 +28.1% ₹3,134 more
Fixed deposit at 6.5% ₹12,343 +23.4% ₹3,601 more

The NIFTY 50 figure is the index itself over the same dates, which like this page counts price only and no dividends — so the two are measured the same way. The fixed deposit line assumes a steady 6.5% a year for the whole period. No bank held one rate that long: Indian deposit rates ran from around 9% in 2014 to about 5.5% in 2021. Treat it as a yardstick, not a record of what a deposit actually paid.

Year by year

YearChange
2026 +3.8%
2025 -23.7%
2024 +45.3%
2023 +51.8%

Mankind Pharma on the record

All-time high
₹2,998
23 Dec 2024
52-week range
₹1,910 – ₹2,674
Deepest fall
-35.7%
23 Dec 2024 to 23 Mar 2026
Market cap
₹94,174 Cr

How this was worked out

₹10,000 at ₹1,430 a share buys 6.99 shares. Held to the close of 11 Sep 2026 at ₹2,280, those shares are worth ₹15,944. Dividends are not included, and neither are brokerage, taxes or charges — the real figure would differ on both counts.

Data covers 09 May 2023 to 11 Sep 2026 (833 trading days), from end-of-day NSE prices. This page is a record of what prices did. It is not advice, and nothing here is a recommendation to buy or sell — read the disclaimer.

Companies of a similar size